title: Pharmacological mechanisms underlying switching from the large-scale depolarization wave to segregated activity in the mouse central nervous system.
abstract: During the early development of the nervous system, synchronized activity is observed in a variety of structures, and is considered to play a fundamental role in neural development. One of the most striking examples of such activity is the depolarization wave reported in chick and rat embryos. In the accompanying paper (Momose-Sato et al., 2012), we have demonstrated that a depolarization wave is also present in the mouse embryo by showing large-scale optical waves, which spread remarkably over the central nervous system, including the spinal cord, hindbrain, cerebellum, midbrain, and forebrain. In the present study, we examined the pharmacological nature of the mouse depolarization wave and its developmental changes. We show here that two types of switching in pharmacological characteristics occur during development. One is that the depolarization wave is strongly dependent on nicotinic acetylcholine receptors during the early developmental stage [embryonic day (E)11-12], but is dominated by glutamate at the later stage (E13 onwards). The second is that γ-aminobutyric acid (GABA), which acts as an excitatory mediator of the depolarization wave during the early phase, becomes an inhibitory modulator by E14. These changes seemed to occur earlier in the hindbrain than in the spinal cord. Furthermore, we show that the second switch causes the loss of synchronization over the network, resulting in the disappearance of the depolarization wave and segregation of the activity into discrete regions of the medulla and spinal cord. We suggest that pharmacological switching is a possible mechanism underlying replacement of the primordial correlated network by a mature neuronal circuit.
authors.affiliation: Department of Health and Nutrition, College of Human Environmental Studies, Kanto Gakuin University, 1-50-1 Mutsuura-Higashi, Kanazawa-ku, Yokohama, 236-8503, Japan. yms@kanto-gakuin.ac.jp
authors.forename: Yoko
authors.initials: Y
authors.lastname: Momose-Sato
authors.forename: Tomoharu
authors.initials: T
authors.lastname: Nakamori
authors.forename: Katsushige
authors.initials: K
authors.lastname: Sato
mesh_terms: D000367:Age Factors; D000818:Animals; D001931:Brain Mapping; D001933:Brain Stem / Q000187:drug effects / Q000196:embryology*; D004305:Dose-Response Relationship, Drug; D004558:Electric Stimulation / Q000379:methods; D004622:Embryo, Mammalian; D018683:Excitatory Amino Acid Agents / Q000494:pharmacology; D018682:GABA Agents / Q000494:pharmacology; D018684:Glycine Agents / Q000494:pharmacology; D066298:In Vitro Techniques; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology*; D051379:Mice; D008813:Mice, Inbred ICR; D009434:Neural Pathways / Q000196:embryology; D018733:Nicotinic Antagonists / Q000494:pharmacology; D018490:Serotonin Agents / Q000494:pharmacology; D013116:Spinal Cord / Q000187:drug effects / Q000196:embryology*; D013127:Spinal Nerves / Q000187:drug effects / Q000502:physiology; D014630:Vagus Nerve / Q000187:drug effects / Q000196:embryology; D056969:Voltage-Sensitive Dye Imaging
chemical_list: D018683:Excitatory Amino Acid Agents; D018682:GABA Agents; D018684:Glycine Agents; D018733:Nicotinic Antagonists; D018490:Serotonin Agents